Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2005
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1691958A Enos mutants useful for gene therapy
11/02/2005CN1225557C Method for producing blood vessel diseases gene medicine-blood vessel endothelium growth gene-2 naked DNA by microorganism cloning vehicle
11/02/2005CN1225476C Human cervical cancer 1 protooncogene and protein encoded therein
11/02/2005CN1225286C Short interference ribonucleic acid as novel anti-tumor gene therapeutic medicine
11/02/2005CN1225285C Gene therapeutics
11/01/2005US6960690 Process of making a compound by forming a polymer from a template drug
11/01/2005US6960650 Nucleotide sequences coding proteins for use in the treatment of tumors
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960569 Hepatitis C virus non-structural NS3/4A fusion gene
11/01/2005US6960562 Administering to said mammal a megakaryocyte stimulating factor (MSF) or alternatively spliced variant to reduce a symptom of osteoarthritis in a mammal
11/01/2005US6960558 Method of screening for anti-obesity agents using ciliary neutrophic factor receptor
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960431 Inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a therapeutic peptide or a derivative thereof and peptide associated with a transporter that is capable of
11/01/2005US6960351 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005CA2303526C Hepatitis c virus cell culture system
11/01/2005CA2157063C Recombinant dna viral vector for transfecting animal cells
10/2005
10/29/2005WO2006126982A2 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
10/29/2005CA2564988A1 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
10/29/2005CA2501422A1 Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
10/27/2005WO2005101021A1 Diagnostics and therapeutics for diseases associated with g protein-coupled adrenergic alpha-1d-receptor (adra1d)
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100577A1 Method for gene delivery to neuronal cells
10/27/2005WO2005100576A2 Replication competent viruses capable of silencing virus inhibitory factor expression
10/27/2005WO2005100563A1 Follistatin mutant polypeptide
10/27/2005WO2005100562A1 OSTEOPONTIN siRNA
10/27/2005WO2005100559A1 Extranuclear rna splicing in neuronal dendrites
10/27/2005WO2005100558A1 Cd40 ligand mutant and utilization of the same
10/27/2005WO2005100447A1 Peg-functional nucleic acid conjugate
10/27/2005WO2005100393A1 Methods and compositions for modulating cardiac contractility
10/27/2005WO2005100392A2 Treatment of neuropathic pain with zinc finger proteins
10/27/2005WO2005100383A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection
10/27/2005WO2005099772A2 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death
10/27/2005WO2005099771A2 Methods and compositions for treating neuropathic and neurodegenerative conditions
10/27/2005WO2005099770A2 Pancreatic islet microrna and methods for inhibiting same
10/27/2005WO2005099763A2 Composition for intracellular transfer of a nucleic acid
10/27/2005WO2005049845A3 Oncolytic herpes simplex virus encoding a heterologous nitroreductase
10/27/2005WO2005037854A3 Immunogenic peptides
10/27/2005WO2004081030A8 Peptides selectively lethal to malignant and transformed mammalian cells
10/27/2005WO2004078940A8 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1
10/27/2005WO2003106643A3 Novel polynucleotides encoding lamprey gnrh-iii
10/27/2005WO2003102016A3 Amyloid peptide inactivating enzyme to treat alzheimer's disease
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050241012 Multigene profiling in the kidney to tailor drug therapy
10/27/2005US20050241008 Transgenic models of Alzheimer's disease and uses therefor in the treatment of a variety of neurodegenerative diseases
10/27/2005US20050241007 Frog prince, a transposon vector for gene transfer in vertebrates
10/27/2005US20050240009 T-cell epitopes in staphylococcal enterotoxin b
10/27/2005US20050240008 Novel protein, dna thereof and process for producing the same
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239739 Conjugates and compositions for cellular delivery
10/27/2005US20050239738 Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization
10/27/2005US20050239737 Identification of molecular interaction sites in RNA for novel drug discovery
10/27/2005US20050239735 Enhancement of immune responses
10/27/2005US20050239734 C-class oligonucleotide analogs with enhanced immunostimulatory potency
10/27/2005US20050239733 Sequence requirements for inhibitory oligonucleotides
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239731 chemically synthesized double stranded siNA against p38 RNA; use against diseases such as cancer, inflammatory, autoimmune, and/or proliferative disorders
10/27/2005US20050239729 Incorporating the pro-apoptotic protein BAX and autoantigens adenoviral protein E3-GP19k and Delta BCL-2 into an injectable antidiabetic or hypoglycemic formulation; prevention, diagnosis and monitoring of diabetic patients
10/27/2005US20050239728 Double stranded rna structures and constructs, and methods for generating and using the same
10/27/2005US20050239727 for use in cosmetics, drugs
10/27/2005US20050239701 Transient and/or permanent modification of sexual behavior and/or fertility using recombinant chimeric GnRH
10/27/2005US20050239700 Treatment of cancer using antibodies to LRRC15
10/27/2005US20050239699 Remedy for infections
10/27/2005US20050239687 Complex comprising transfecting peptide vector and short interferring RNA, used as medicaments, in human and veterinary medicine, in human and animal gene therapy, in particular in hereditary diseases, as antiviral agents, as anticarcinogenic agents and inhibitors of gene overexpression
10/27/2005US20050239204 Multifunctional molecular complexes for gene transfer to cells
10/27/2005US20050239203 Regulation of endogenous gene expression in cells using zinc finger proteins
10/27/2005US20050239202 Methods and compositions for inhibiting the function of polynucleotide sequences
10/27/2005US20050239188 Virus envelope vector for gene transfer
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239129 Identification of genes having a role in the presentation of diabetic nephropathy
10/27/2005US20050239121 Non-aggregating non-quenching oligomers comprising nucleotide analogs; methods of synthesis and use thereof
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239094 Compositions and methods for inducing and regulating bone formation
10/27/2005US20050239069 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy
10/27/2005US20050239064 Methods and compositions based on protein interactions with mastermind
10/27/2005US20050239052 Cloning of rhadinovirus genome and methods for its use
10/27/2005US20050238722 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/27/2005US20050238662 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying
10/27/2005US20050238660 Cpg formulations and related methods
10/27/2005US20050238629 Vector capable of transduction non-dividing or slowly diviving cell; gene expression in protein; genetic engineering
10/27/2005US20050238628 Methods for treating cancer
10/27/2005US20050238627 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
10/27/2005US20050238626 Antigen specific T cell therapy
10/27/2005US20050238624 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
10/27/2005US20050238622 Compositions and methods for treating cancer with an oncolytic viral agent
10/27/2005US20050238619 Method for the delivery of sustained release agents
10/27/2005US20050238606 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin water solution of nucleic acid for delivery to hair follicles to inhibit hair growth
10/27/2005US20050238578 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders
10/27/2005CA2563388A1 Microrna and methods for inhibiting same
10/27/2005CA2562885A1 Follistatin variant polypeptide
10/27/2005CA2562830A1 Replication competent viruses capable of silencing virus inhibitory factor expression
10/27/2005CA2562193A1 Treatment of neuropathic pain with zinc finger proteins
10/27/2005CA2561714A1 Methods and compositions for treating neuropathic and neurodegenerative conditions
10/27/2005CA2561565A1 Methods for repression of phospholamban gene and modulating cardiac contractility
1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 870